SACOME, A NEW IMAGING MARKER OF NEPRILYSIN ACTIVITY AND DISTRIBUTION

François Tournoux(Centre Hospitalier de l’Université de Montréal), Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal), D. R. Petrenyov(Centre Hospitalier de l’Université de Montréal), Valentin R. Teyssier(Centre Hospitalier de l’Université de Montréal)
Canadian Journal of Cardiology
October 1, 2019
10.1016/j.cjca.2019.07.489
Cited by 0

Related Papers

The Use of <sup>18</sup>F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience
|Journal of Nuclear Medicine|2012|512
Global Variations in Heart Failure Etiology, Management, and Outcomes
|JAMA|2023|164
<sup>18</sup>F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to <sup>18</sup>F-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial
|Journal of Nuclear Medicine|2010|154
The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis
|Journal of Nuclear Cardiology|2013|87
Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging–Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease
|Circulation Cardiovascular Imaging|2016|86